TMBIM6 and amyotrophic lateral sclerosis: This study investigates the therapeutic effects of BI1 overexpression in ALS, both in vivo and in vitro, and finds that it can reduce SOD1G93A-induced apoptosis, nuclear damage, mitochondrial dysfunction, and motor neuron axonal degeneration.